Literature DB >> 20146103

Clinical implication and mitotic effect of CD44 cleavage in relation to osteopontin/CD44 interaction and dysregulated cell cycle protein in gastrointestinal stromal tumor.

Kai-Hsi Hsu1, Hung-Wen Tsai, Pin-Wen Lin, Yun-Shang Hsu, Yan-Shen Shan, Pei-Jung Lu.   

Abstract

BACKGROUND: CD44 and osteopontin (OPN) are functionally related molecules that, alone or in combination, play miscellaneous biological and pathophysiologic roles. CD44 cleavage, one unique feature of CD44, occurs in human cancers, but its function remains unclear. This study aimed to assess the clinicopathologic significance and mechanism of CD44 cleavage in gastrointestinal stromal tumor (GIST) with respect to OPN and OPN/CD44 interaction.
MATERIALS AND METHODS: CD44 cleavage was evaluated by immunoblotting in 31 primary GIST tumor specimens with paired normal tissues. OPN/CD44 interaction was examined by in situ proximity ligation assay. The associations of CD44 cleavage activity with clinicopathologic parameters, cyclin D1 expression, beta-catenin expression, OPN expression, and OPN/CD44 interaction were analyzed.
RESULTS: CD44 cleavage activity was demonstrated in 87.1% of GIST, in contrast to its absence in normal tissues. Increased CD44 cleavage activity was significantly associated with enhanced mitosis by multivariate analysis, in addition to being related to tumor size, recurrence, high-risk status, and poor survival by univariate analysis. Mitosis was significantly higher in GIST with increased CD44 cleavage activity, which also positively correlated with tumor-specific beta-catenin and cyclin D1 overexpression, indicating a mitotic effect through aberrant cell cycle. Both OPN and OPN/CD44 interactions were significantly associated with CD44 cleavage.
CONCLUSION: Our study demonstrates the clinicopathological significance of CD44 cleavage in GIST. There is a significantly increased mitosis associated with CD44 cleavage in relation to OPN/CD44 interaction and dysregulated cell cycle in GIST.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146103     DOI: 10.1245/s10434-010-0927-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.

Authors:  Alexander Pietras; Amanda M Katz; Elin J Ekström; Boyoung Wee; John J Halliday; Kenneth L Pitter; Jillian L Werbeck; Nduka M Amankulor; Jason T Huse; Eric C Holland
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

2.  Osteopontin promotes infarct repair.

Authors:  Itai Rotem; Tal Konfino; Tal Caller; Yeshai Schary; Olga Shaihov-Teper; Dahlia Palevski; Nir Lewis; Daria Lendengolts; Nili Naftali-Shani; Jonathan Leor
Journal:  Basic Res Cardiol       Date:  2022-10-14       Impact factor: 12.416

Review 3.  Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.

Authors:  Jianqiang Chen; Jianding Zhou; Jie Lu; Hua Xiong; Xueli Shi; Liang Gong
Journal:  BMC Cancer       Date:  2014-01-13       Impact factor: 4.430

4.  Human Malignant Rhabdoid Tumor Antigens as Biomarkers and Potential Therapeutic Targets.

Authors:  Timothy Hua; Ziwei Zeng; Junji Chen; Yu Xue; Yan Li; Qingxiang Sang
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

5.  Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.

Authors:  Cheng-Lin Wu; Ying-Jui Chao; Ta-Ming Yang; Yi-Ling Chen; Kung-Chao Chang; Hui-Ping Hsu; Yan-Shen Shan; Ming-Derg Lai
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

6.  Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors.

Authors:  Kai-Hsi Hsu; Hung-Wen Tsai; Pin-Wen Lin; Yun-Shang Hsu; Pei-Jung Lu; Yan-Shen Shan
Journal:  World J Surg Oncol       Date:  2014-06-20       Impact factor: 2.754

Review 7.  Osteopontin b and c Splice isoforms in Leukemias and Solidzzm321990Tumors: Angiogenesis Alongside Chemoresistance

Authors:  Akram Mirzaei; Saeed Mohammadi; Seyed H Ghaffari; Marjan Yaghmaie; Mohammad Vaezi; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.